EcoDrugPlus

Endothelin Converting Enzyme 1

Ensembl ID : ENSDORG00000016671
Gene Symbol: ECE1
3 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSDORG00000014305
Gene Symbol: EDNRA
4 Cross references
269 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSDORG00000008982
Gene Symbol: EDNRB
3 Cross references
267 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSDORG00000007731
Gene Symbol: EZH2
4 Cross references
236 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSDORG00000013051
Gene Symbol: EGFR
3 Cross references
286 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSDORG00000010204
Gene Symbol: EPHX2
4 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSDORG00000014861
Gene Symbol: ERBB2
4 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSDORG00000001076
Gene Symbol: ERBB3
4 Cross references
280 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSDORG00000013025
Gene Symbol: ERBB4
4 Cross references
320 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSDORG00000010443
Gene Symbol: ESR1
3 Cross references
212 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSDORG00000029253
Gene Symbol: ESR2
3 Cross references
274 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSDORG00000005752
Gene Symbol: ESRRG
4 Cross references
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).